Cessation of Somatostatin Analogues After PRRT in Mid-Gut Neuroendocrine Tumours

Conditions: Neuroendocrine Tumors Interventions: Drug: Cessation of somatostatin analogues; Drug: Continuation of somatostatin analogues Sponsors: Australasian Gastro-Intestinal Trials Group; Canadian Cancer Trials Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials